News & Views
Aalto Bio Reagents Signs Distribution Partner Agreement in China with Seebio Biotech
Apr 12 2018
Aalto Bio Reagents yesterday signed its first distribution agreement with a Chinese partner, Seebio Biotech Co Ltd, while on a Team Ireland led trade mission. This major trade mission, attended by An Tánaiste Simon Coveney, aims to build strategic relationships with potential business partners like Seebio Biotech. Irish trade with China has doubled in the last 4 years and with the Chinese in-vitro diagnostic market expected to triple by 2022, this presents an excellent opportunity for companies such as Aalto Bio Reagents to further expand its customer reach and to capitalise on this growth.
Aalto Bio already has a strong presence in the IVD market in Europe, and has recently expanded into Brazil, Japan, Korea and the U.S. with the growing demand for its tropical virus antigens and antibodies. Philip Noone, CEO of Aalto Bio Reagents, said “the signing of this first ever distribution agreement with a Chinese partner opens up a whole new territory for us and will help broaden our global presence. Our industry has an unrelenting requirement for access to the most scientifically proven raw materials, a broader range of flexible controls and faster diagnostics, and China is no exception. With Seebio’s extensive experience in the field of life science, we are confident that they are the perfect partner to grow and develop our business in China.”
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 24 2024 Jakarta, Indonesia
Apr 25 2024 Istanbul, Turkey
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA